- Home
- ZIMV
ZIMV
ZimVie Inc.
as 11-20-2024 4:00pm EST
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | PALM BEACH GARDEN |
| Market Cap: | 434.5M | IPO Year: | N/A |
| Target Price: | $18.33 | AVG Volume (30 days): | 161.7K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.95 - $22.40 | Next Earning Date: | 10-30-2024 |
| Revenue: | $451,294,000 | Revenue Growth: | 267.15% |
| Revenue Growth (this year): | 0.83% | Revenue Growth (next year): | 1.27% |
Latest ZimVie Inc. News
ZIMV Breaking Stock News: Dive into ZIMV Ticker-Specific Updates for Smart Investing
GuruFocus.com
21 days ago
ZimVie Inc (ZIMV) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
Motley Fool
21 days ago
ZimVie (ZIMV) Q3 2024 Earnings Call Transcript
GlobeNewswire
22 days ago
ZimVie Reports Third Quarter 2024 Financial Results
GlobeNewswire
23 days ago
ZimVie to Present at the UBS Global Healthcare Conference
GlobeNewswire
a month ago
ZimVie to Report Third Quarter Financial Results on October 30, 2024
GuruFocus.com
a month ago
ZimVie Inc (ZIMV) Q2 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ...
GuruFocus.com
2 months ago
Neuberger Berman Group LLC's Strategic Acquisition in ZimVie Inc
Motley Fool
4 months ago
ZimVie (ZIMV) Q2 2024 Earnings Call Transcript
Compare ZIMV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZIMV ZimVie Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.